Hesham Q. Rawashdeh, MD*, Areej Al Assassfeh, MD, Duaa T. Daradkeh, MD, Ibrahim Al keelany, MD, Rawan Al Foqaha, MD

OUTCOMES OF INTRAVITREAL BEVACIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: EXPERIENCE FROM A JORDANIAN MILITARY HOSPITAL

Aim: To evaluate the functional, anatomical and safety outcomes of using intravitreal bevacizumab (IVB) in Jordanian military hospitals for treatment-naïve neovascular age-related macular degeneration (nAMD). Methods: This retrospective study involved the use of IVB in treatment-...

OUTCOMES OF INTRAVITREAL BEVACIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: EXPERIENCE FROM A JORDANIAN MILITARY HOSPITAL

Aim: To evaluate the functional, anatomical and safety outcomes of using intravitreal bevacizumab (IVB) in Jordanian military hospitals for treatment-naïve neovascular age-related macular degeneration (nAMD). Methods: This retrospective study involved the use of IVB in treatment-...